Published in Trends Cell Biol on December 19, 2016
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Evidence for cardiomyocyte renewal in humans. Science (2009) 14.17
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 10.27
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 6.30
Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest (1975) 5.72
Mammalian heart renewal by pre-existing cardiomyocytes. Nature (2012) 5.56
Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell (2006) 5.03
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A (2012) 4.85
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68
3D bioprinting of tissues and organs. Nat Biotechnol (2014) 4.66
Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell (2012) 4.22
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature (2011) 4.10
Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci (2008) 3.86
A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One (2011) 3.39
The extracellular matrix at a glance. J Cell Sci (2010) 3.37
Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell (2013) 3.35
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med (2014) 3.23
Muscular thin films for building actuators and powering devices. Science (2007) 3.21
Chemically defined generation of human cardiomyocytes. Nat Methods (2014) 2.84
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66
Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64
Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation (2013) 2.57
Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics (2010) 2.55
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res (2012) 2.51
Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circ Res (2014) 2.47
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell (2012) 2.38
Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res (2008) 2.36
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J (1997) 2.33
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell (2013) 2.33
NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods (2011) 2.29
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells (2007) 2.28
Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation (2006) 2.26
Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A (2009) 2.25
Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells (2005) 2.23
Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells (2006) 2.20
Differential cardiac remodeling in preload versus afterload. Circulation (2010) 2.20
Optical imaging of voltage and calcium in cardiac cells & tissues. Circ Res (2012) 2.19
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14
Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res (2004) 2.09
Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol (2003) 2.01
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature (2013) 2.00
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials (2013) 1.97
A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95
Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc Natl Acad Sci U S A (2009) 1.89
Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng (2010) 1.82
Nanowired three-dimensional cardiac patches. Nat Nanotechnol (2011) 1.76
Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res (2010) 1.76
Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol (1992) 1.72
Generation of the epicardial lineage from human pluripotent stem cells. Nat Biotechnol (2014) 1.68
Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res (2010) 1.67
Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66
Biohybrid thin films for measuring contractility in engineered cardiovascular muscle. Biomaterials (2010) 1.61
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun (2014) 1.60
Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater (2006) 1.59
Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun (2008) 1.59
Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture. Biomaterials (2012) 1.57
Phototactic guidance of a tissue-engineered soft-robotic ray. Science (2016) 1.54
Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res (1994) 1.54
Bioengineering Human Myocardium on Native Extracellular Matrix. Circ Res (2015) 1.53
Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation (2012) 1.53
Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol (1992) 1.53
How deeply cells feel: methods for thin gels. J Phys Condens Matter (2010) 1.51
Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med (2013) 1.49
Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A (2009) 1.44
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol (2013) 1.38
Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One (2011) 1.34
Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells (2005) 1.31
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A (2013) 1.29
Restoration of resting sarcomere length after uniaxial static strain is regulated by protein kinase Cepsilon and focal adhesion kinase. Circ Res (2004) 1.24
Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol Sci (2012) 1.24
Influence of electrical axis of stimulation on excitation of cardiac muscle cells. Circ Res (1991) 1.23
Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials (2007) 1.23
Induced pluripotent stem cells in cardiovascular drug discovery. Circ Res (2013) 1.22
Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. Tissue Eng Part A (2008) 1.20
Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep (2014) 1.20
The organization of adherens junctions and desmosomes at the cardiac intercalated disc is independent of gap junctions. J Cell Sci (2003) 1.16
The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials (2012) 1.16
Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports (2014) 1.12
Rapid cellular phenotyping of human pluripotent stem cell-derived cardiomyocytes using a genetically encoded fluorescent voltage sensor. Stem Cell Reports (2014) 1.11
Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J Biomech Eng (2014) 1.08
Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta (2014) 1.06
Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. Biomaterials (2015) 1.06
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep (2014) 1.00
Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med (2014) 0.99
Morphology, composition, and function of struts between cardiac myocytes of rat and hamster. Cell Tissue Res (1987) 0.99
Stacking of aligned cell sheets for layer-by-layer control of complex tissue structure. Biomaterials (2011) 0.97
Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials (2014) 0.96
Necking and failure of constrained 3D microtissues induced by cellular tension. Proc Natl Acad Sci U S A (2013) 0.96
Microbioreactor arrays for full factorial screening of exogenous and paracrine factors in human embryonic stem cell differentiation. PLoS One (2012) 0.95